Multimodal measurable residual disease detection in acute myeloid leukemia: From technology to clinical integration
{{output}}
Measurable residual disease (MRD) is an increasingly vital tool in predicting the risk of relapse in patients with acute myeloid leukemia (AML), with a growing role in directing therapeutic choices. The vast phenotypic and genomic heterogeneity of AML preclude... ...
